“I have been doing clinical and basic science research for most of my career. I am a clinician-scientist. I started the Center for Women’s Health Research at Meharry, which was the first center that looked at diseases that disproportionately impacted women of color almost 15 or so years ago. So, I’ve been involved in research for a long period of time. So, one of the things that I knew is that the mRNA—the messenger RNA technology—has been in development for the last 12 years. So even though you hear this thing about warp speed, believe me, that did not warp speed. It just happened to be at a time, at a point in time, where it was ready for prime time. And, so, looking for a candidate vaccine to actually showcase this technology. So, I was very comfortable with that.”